Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis [Phase 1, Phase 2]
Clinical trial update for fecal microbiota transplant in pediatric active ulcerative colitis and pediatric active Crohn's colitis (Phase 1/P…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade [Phase 3]
A Phase 3 trial evaluating high-dose interval vitamin D supplementation in patients with inflammatory bowel disease receiving Remicade.
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]
An extension study (Phase 2) evaluating long-term safety and tolerability of UTTR1147A in moderate-to-severe Ulcerative Colitis or Crohn's D…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC) [Phase 3]
Phase 3 trial update for subcutaneous CT-P13 (infliximab) in moderately to severely active ulcerative colitis; study completed with results …
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis [Phase 4]
A Phase 4 trial update on adherence of a 1,600 mg single-tablet 5-ASA treatment for Ulcerative Colitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis [Phase 2]
Phase 2 trial update reporting efficacy and safety of orally administered BBT-401-1S in subjects with Ulcerative Colitis has completed with …
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2]
Phase 2 trial of LY3471851 in adults with moderately to severely active ulcerative colitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 study investigating SHR0302 for moderately to severely active ulcerative colitis; results and safety data are not yet disclosed.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC) [Phase 2]
Phase 2 study of GB004 in adults with active ulcerative colitis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis [Phase 3]
Phase 3 trial update evaluating AJM300 in active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC [Phase 2]
Phase 2 trial evaluating ALTB-168 for moderate to severe ulcerative colitis that is refractory to anti-TNF or anti-integrin therapy; study t…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update for CU104 in moderate-severe ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis [Phase 4]
Phase 4 randomized trial comparing early azathioprine plus infliximab to steroids plus azathioprine for acute severe ulcerative colitis has …
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET [Phase 4]
Phase 4 trial update evaluating intensive golimumab treatment in ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab [Phase 4]
A Phase 4 clinical trial comparing standard of care vs treat-to-target with telemonitoring and patient education in patients with ulcerative…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC) [Phase 2]
Phase 2 clinical trial update for PN-943 in adults with moderate to severe active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) [Phase 2]
Phase 2 trial evaluating UTTR1147A versus placebo and vedolizumab in moderate-to-severe ulcerative colitis completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: HF2 Therapy in the Treatment of Active Ulcerative Colitis [Phase 1, Phase 2]
Phase 1/2 trial update for HF2 therapy in active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of diosmin in patients with ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease [Phase 4]
A Phase 4 clinical trial evaluating saffron as an anti-inflammatory treatment in patients with ulcerative colitis is underway but status is …
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy [Phase 2]
Phase 2 clinical trial evaluating Ravagalimab (ABBV-323) for moderate to severe ulcerative colitis in patients who failed prior therapy; stu…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis [Phase 1, Phase 2]
Clinical trial update exploring the role of intestinal protozoa and helminths in the course of Ulcerative Colitis across Phase 1 and Phase 2…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) [Phase 4]
Phase 4 trial update for an anti-TNF discontinuation strategy in Crohn's disease and inflammatory bowel disease (including ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis [Phase 2]
Phase 2 trial results for ABX464 in patients with moderate to severe active ulcerative colitis have been posted. The update covers efficacy …
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating GLPG3970 as an oral treatment for 6 weeks in adults with ulcerative colitis has completed with results posted.